Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroendocrine Tumors, NET”

160 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 160 results

Not applicableLooking for participantsNCT06402695
What this trial is testing

Observational Study on GEP-and Pulm-NET Treated at FPG

Who this might be right for
Neuroendocrine TumorsGep NetPulmonary Neuroendocrine Neoplasm
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 650
Not applicableUnknownNCT03958188
What this trial is testing

PreOPerative Imaging of NeuroEndocrine Tumors

Who this might be right for
Neuro-endocrine TumorsSmall Intestine Cancer
Hospices Civils de Lyon 47
Testing effectiveness (Phase 2)Study completedNCT03043664
What this trial is testing

Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
Duke University 22
Not applicableLooking for participantsNCT07195500
What this trial is testing

Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma

Who this might be right for
NeuroblastomaPheochromocytomaParaganglioma
Nanjing First Hospital, Nanjing Medical University 30
Testing effectiveness (Phase 2)Study completedNCT02162446
What this trial is testing

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
Ipsen 12
Testing effectiveness (Phase 2)Study completedNCT02955069
What this trial is testing

Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)

Who this might be right for
Well-differentiated Non-functional NET of Thoracic OriginWell-differentiated Non-functional NET of Gastrointestinal OriginWell-differentiated Non-functional NET of Pancreatic Origin+1 more
Novartis Pharmaceuticals
Not applicableStudy completedNCT03840720
What this trial is testing

The Patient's Journey - the Time to Final Diagnosis in Patients With SiNET

Who this might be right for
Neuroendocrine Tumors
Vastra Gotaland Region 20
Not applicableStudy completedNCT03791346
What this trial is testing

Pancreatectomy for NET: External Evaluation of WHO 2017 Grading System

Who this might be right for
Pancreatic Surgery
University Hospital, Montpellier 138
Early research (Phase 1)UnknownNCT02693067
What this trial is testing

PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver

Who this might be right for
Neuroendocrine Tumors Metastatic to the Liver
Provectus Biopharmaceuticals, Inc. 12
Not applicableNot Yet RecruitingNCT07635316
What this trial is testing

Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Novartis Pharmaceuticals 4,023
Testing effectiveness (Phase 2)Looking for participantsNCT07357623
What this trial is testing

Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors

Who this might be right for
Pulmonary Neuroendocrine Tumor
Shanghai Chest Hospital 96
Not applicableLooking for participantsNCT07554560
What this trial is testing

Nutrition Intervention for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Neuroendocrine Tumor (NET)
Children's Hospital of Philadelphia 18
Not applicableNo Longer AvailableNCT01980732
What this trial is testing

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Who this might be right for
Carcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors
Andrei Iagaru
Large-scale testing (Phase 3)Study completedNCT01524783
What this trial is testing

Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)

Who this might be right for
Advanced NET of GI OriginAdvanced NET of Lung OriginNeuroendocrine Tumors
Novartis Pharmaceuticals 302
Not applicableUnknownNCT03982264
What this trial is testing

Endoscopic Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm

Who this might be right for
Rectal Neuroendocrine Tumor
Nanfang Hospital, Southern Medical University 90
Not applicableStudy completedNCT02730104
What this trial is testing

Community-based Neuroendocrine Tumor (NET) Research Study

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
Ipsen 100
Testing effectiveness (Phase 2)Looking for participantsNCT04924075
What this trial is testing

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Who this might be right for
Pheochromocytoma/ParagangliomaPancreatic Neuroendocrine TumorVon Hippel-Lindau Disease+2 more
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT01234168
What this trial is testing

Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

Who this might be right for
Neuroendocrine TumorsCarcinoid Syndrome
Ipsen 340
Not applicableUnknownNCT05268952
What this trial is testing

Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)

Who this might be right for
Neuroendocrine Tumors
University Hospital, Antwerp 100
Testing effectiveness (Phase 2)Study completedNCT02299089
What this trial is testing

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Who this might be right for
AcromegalyNeuroendocrine Tumors
Camurus AB 12
Load More Results
116
355